Percutaneous Coronary Intervention (PCI) Clinical Trials

Clinical trials related to Percutaneous Coronary Intervention (PCI) Procedure

Impact of Drug-Coated Balloon Procedural Factors on Angiographic and Clinical Outcomes of Percutaneous Coronary Intervention for De Novo Lesions: A Multicenter, Prospective, Observational Registry

Status: Recruiting
Location: See all (7) locations...
Study Type: Observational
SUMMARY

This registry aimed to investigate drug-coated balloon procedural factors (particularly delivery time and inflation duration) to evaluate the impact on angiographic and clinical outcomes in patients undergoing percutaneous coronary intervention for de novo coronary lesions.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• Age ≥18 years

• Stable coronary artery disease or unstable angina

• De novo coronary lesion (reference vessel diameter 2.25-4.0 mm; lesion length ≤40 mm)

• Planned DCB strategy for PCI

• Written informed consent

Locations
Other Locations
China
Chuzhou First People's Hospital
RECRUITING
Chuzhou
Huai'an Second People's Hospital
RECRUITING
Huai'an
Lianyungang First People's Hospital
RECRUITING
Lianyungang
Nanjing First Hospital
RECRUITING
Nanjing
Tongling People's Hospital
RECRUITING
Tongling
Xuzhou Second People's Hospital
RECRUITING
Xuzhou
Yixing People's Hospital
RECRUITING
Yixing
Contact Information
Primary
Fei Ye, MD
doctor_ye@126.com
18951670287
Backup
Tian-lei Zhang, MD
Time Frame
Start Date: 2026-09-01
Estimated Completion Date: 2028-06-30
Participants
Target number of participants: 500
Treatments
DCB-Treated De Novo Lesion
Patients undergoing drug-coated balloon treatment for de novo coronary lesions
Sponsors
Leads: Nanjing First Hospital, Nanjing Medical University

This content was sourced from clinicaltrials.gov